RAC 3.31% $1.61 race oncology ltd

Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-66

  1. 709 Posts.
    lightbulb Created with Sketch. 277
    Hi JD
    There are many companies following the  virotherapy and CPI route. Have a look at Targovax CPI resistant melanoma results from last year (from memory 35% response rate treating failed cpi treated cases)
    If you want more science have a look at this paper
    https://www.cell.com/molecular-therapy-family/oncolytics/fulltext/S2372-7705(21)00024-3
    specifically look at the response rate figure from the same model (B-16) that Race has used and compare the results. You will see there is complete inhibition of tumor growth and the activation of a systemic abscopal  effect.
    There are many other examples.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.61
Change
-0.055(3.31%)
Mkt cap ! $273.4M
Open High Low Value Volume
$1.66 $1.68 $1.61 $271.5K 166.3K

Buyers (Bids)

No. Vol. Price($)
1 1996 $1.61
 

Sellers (Offers)

Price($) Vol. No.
$1.68 1305 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.